side effects and cost-effectiveness are needed before triflusal can be considered a candidate for routine therapy in myocardial infarction. The TIM trial may offer an alternative to aspirin, a challenge which will certainly stimulate further research in this field.
Almost a century after Einthoven's invention of the string galvanometer, the surface electrocardiograph retains its central place in cardiological diagnosis. In seeking to extract yet more information from the standard 12 lead ECG, much attention has been given in recent years to the measurement of QT dispersion. The QT interval reflects the duration of depolarization and repolarization of the ventricular myocardium. Abnormal prolongation of the QT interval (congenital or acquired) predisposes to ventricular tachycardia of 'torsade de pointes' morphology. Abnormal QT dispersion (measured as the difference between the longest and the shortest QT duration in the 12 ECG leads) reflects inhomogeneous repolarization of ventricular muscle which may provide a substrate for serious ventricular arrhythmias. In the context of ischaemic heart disease, researchers have explored the measurement of QT dispersion as a potential marker of arrhythmic risk, of myocardial ischaemia and of myocardial viability. In none of these applications has the technique so far established a place in routine clinical practice, though some progress has been made in our understanding of the measurement and significance of QT dispersion. In population studies, QT dispersion has been reported to be an independent predictor of long-term cardiovascular mortality in subjects with known cardiovascular disease at entry [1] . In patients with acute myocardial infarction, measurement of QT dispersion has shown little promise as a predictor of long-term mortality risk for individuals [2] . However, the link between myocardial ischaemia and increased QT dispersion has been elegantly demonstrated in angina patients subjected to atrial pacing [3, 4] . In this issue, Ikonomidis and colleagues report a study of the relationship between QT dispersion and myocardial viability, as detected by dobutamine stress echocardiography, in patients with past myocardial infarction [5] . They also looked for associations between these phenomena, the patency of the infarctrelated artery and the occurrence of ventricular arrhythmias during dobutamine infusion. A low dose dobutamine infusion protocol was chosen (maximum 20 g . kg 1 . min 1 in most patients) to reduce the likelihood of inducing ischaemia during the test; in consequence, the haemodynamic changes were rather small. Their main findings were that the presence of viable myocardium (as assessed by echocardiographic criteria) was associated both with a smaller QT dispersion at rest, and a greater increase in QT dispersion during dobutamine stress, than was seen in its absence. Optimum QT dispersion criteria were found to predict the presence of myocardial viability with 67% sensitivity and 96% specificity. Patients with viable myocardium were more likely to have a patent infarct-related artery and to have ventricular arrhythmias during dobutamine infusion. Occurrence of arrhythmias was also associated with higher measured QT dispersion during dobutamine infusion.
Schneider and colleagues [6] have also related QT dispersion at rest to myocardial viability as assessed by F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) in patients with past myocardial infarction. QT dispersion was lower in patients with substantial amounts of viable myocardium than in those having little or no residual viability in the infarct zone. This study had the added strength of follow-up after revascularization. QT dispersion of c70 ms predicted improvement in left ventricular function with 83% sensitivity and 71% specificity.
Should measurement of QT dispersion now be included in the diagnostic assessment of patients being considered for coronary revascularization after acute myocardial infarction? The literature indicates that there are grounds for caution in both the technical procedure and its conceptual basis. Although the technique is non-invasive and readily available, a sizeable minority of patients are unsuitable because of atrial fibrillation, left bundle branch block or ambiguous T wave termination in multiple leads. Measurement error is large in proportion to the parameter being estimated (particularly where ST-T amplitude is low), whether performed manually or by computer [7] . The postero-inferior ventricular myocardium is not well represented in the standard 12-lead ECG. Because of the physics of their derivation, the standard limb leads provide two and not six independent measures of QT dispersion [7] . The biophysical basis of QT dispersion, and the pathological processes which affect it, are not well understood. The literature in this area therefore depends heavily on empirical observations of QT dispersion in groups of patients defined by existing diagnostic tests and/or by outcome. Large numbers of small studies will from time to time produce 'statistically significant' associations by chance, and the test of replication is particularly important. Even real differences between groups may not yield predictive information for the individual patient. The two studies cited have usefully given estimates of sensitivity and specificity for detection of viable myocardium. However, these are derived from training sets of relatively small numbers of patients and need to be validated prospectively in larger studies using clinically important outcome measures.
Although our understanding of QT dispersion has progressed in the last decade, the technique is not yet ready for clinical application outside research. As with any new diagnostic test, we need first to know its effectiveness and cost-effectiveness in comparison with alternative management strategies. Can its use improve clinical outcome? If so, in which groups of patients? What are the full costs and benefits of its general adoption -including the consequences of false positive and false negative results? This is a demanding research agenda, but it must be considered even when the test in question looks at first sight to be easy, simple and safe.
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